First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Feb 27
 -0.93 / -0.80%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month+4.29% 3 years+42.23%
3 months+13.98% 5 years+29.81%
1 year+35.31% Since inception+22.60%
Data through 02/27/2015

Quote Details

Previous close$116.16
Open day’s range114.62 – 116.16
Net asset value (NAV)116.06 (02/26/2015)
Daily volume219,054
Average volume (3 months)218,654
Data as of 3:59pm ET, 02/27/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+29.81%+22.29%
Expense Gross exp ratio0.61%0.47%
Risk 5 year sharpe ratio1.251.47
Net assets$2.5B$1.6B
Average market cap$8.9B$35.3B
Average P/E23.926.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ICPT Intercept Pharmaceuticals Inc4.35%
PCYC Pharmacyclics Inc3.78%
NVAX Novavax Inc3.74%
BIIB Biogen3.59%
INCY Incyte Corp3.49%
ILMN Illumina Inc3.46%
CLDX Celldex Therapeutics Inc3.44%
GILD Gilead Sciences3.39%
ALKS Alkermes Plc3.36%
CPHD Cepheid3.33%

To view my watchlist

Not a member yet?

Sign up now for a free account